Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024European PsychiatryOpen Access

Management of cognitive symptoms in schizophrenia.

View Full Paper
Ask AI
Bookmark
Share

Authors

TJT. JupePsychiatric Medical CenterIKI. KourtesisThriasio General Hospital of ElefsinaISIppokratis SarrisFetal Medicine Foundation

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jupe et al. (2024) studied this question.

synapsesocial.com/papers/68e717f9b6db643587690be2https://doi.org/10.1192/j.eurpsy.2024.1567
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials2025 · 1 citations
  2. 2The role of add-on strategies (cognitive enhancers, cognitive remediation)2025
  3. 3NMDA Receptor Dysfunction and Cognitive Impairment in Schizophrenia: Mechanisms, Evidence and Therapeutic Potential2025
  4. 4Cognitive impairment in psychoses and affective disorders: addressing future challenges2025
  5. 5Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways2024 · 6 citations